Research has shown that an upregulation of the IL-21 signaling pathway in the SG of SS patients is associated with increased B-cells enrichment and disease activity (98), suggesting a role for CD11c+ ABC via IL-21 signaling (99). This evidence concerns the gene IL21 and synovial sarcoma.